A new trading day began on Tuesday, with Evolus Inc (NASDAQ: EOLS) stock price up 28.26% from the previous day of trading, before settling in for the closing price of $10.51. EOLS’s price has ranged from $9.25 to $17.82 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 55.81% over the past five years. Meanwhile, its annual earnings per share averaged 66.45%. With a float of $54.70 million, this company’s outstanding shares have now reached $63.25 million.
Let’s look at the performance matrix of the company that is accounted for 273 employees. In terms of profitability, gross margin is 68.25%, operating margin of -13.69%, and the pretax margin is -22.2%.
Evolus Inc (EOLS) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Evolus Inc is 13.62%, while institutional ownership is 78.91%. The most recent insider transaction that took place on Dec 23 ’24, was worth 24,438. In this transaction an insider of this company sold 2,252 shares at a rate of $10.85, taking the stock ownership to the 366,595 shares. Before that another transaction happened on Dec 23 ’24, when Company’s Chief Financial Officer sold 1,586 for $10.85, making the entire transaction worth $17,211. This insider now owns 146,916 shares in total.
Evolus Inc (EOLS) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.01 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 66.45% per share during the next fiscal year.
Evolus Inc (NASDAQ: EOLS) Trading Performance Indicators
Here are Evolus Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.23. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.44.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.91, a number that is poised to hit 0.02 in the next quarter and is forecasted to reach -0.17 in one year’s time.
Technical Analysis of Evolus Inc (EOLS)
Evolus Inc (NASDAQ: EOLS) saw its 5-day average volume 1.04 million, a positive change from its year-to-date volume of 0.97 million. As of the previous 9 days, the stock’s Stochastic %D was 62.50%. Additionally, its Average True Range was 0.82.
During the past 100 days, Evolus Inc’s (EOLS) raw stochastic average was set at 49.36%, which indicates a significant decrease from 80.73% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 115.94% in the past 14 days, which was higher than the 65.75% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.94, while its 200-day Moving Average is $13.28. Nevertheless, the first resistance level for the watch stands at $14.40 in the near term. At $15.32, the stock is likely to face the second major resistance level. The third major resistance level sits at $16.15. If the price goes on to break the first support level at $12.65, it is likely to go to the next support level at $11.82. The third support level lies at $10.90 if the price breaches the second support level.
Evolus Inc (NASDAQ: EOLS) Key Stats
With a market capitalization of 853.58 million, the company has a total of 63,321K Shares Outstanding. Currently, annual sales are 202,090 K while annual income is -61,690 K. The company’s previous quarter sales were 61,090 K while its latest quarter income was -19,170 K.
